BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36919319)

  • 1. [Combined Hormonal Contraception - Which Pill for Which Patient?].
    Quaas P
    Praxis (Bern 1994); 2023; 112(4):205-210. PubMed ID: 36919319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes.
    Dragoman M; Curtis KM; Gaffield ME
    Contraception; 2016 Sep; 94(3):280-7. PubMed ID: 26272309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal Contraception: Systemic Estrogen and Progestin Preparations.
    Verma N; Cwiak C; Kaunitz AM
    Clin Obstet Gynecol; 2021 Dec; 64(4):721-738. PubMed ID: 34668886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of estrogenic components used for hormonal contraception.
    Stanczyk FZ; Winer SA; Foidart JM; Archer DF
    Contraception; 2024 Feb; 130():110310. PubMed ID: 37863464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic hormonal contraception and risk of venous thromboembolism.
    Heikinheimo O; Toffol E; Partonen T; But A; Latvala A; Haukka J
    Acta Obstet Gynecol Scand; 2022 Aug; 101(8):846-855. PubMed ID: 35633036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraception, venous thrombosis and biological plausability.
    Rott H
    Minerva Med; 2013 Apr; 104(2):161-7. PubMed ID: 23514992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogens in oral contraception: considerations for tailoring prescription to women's needs.
    Fruzzetti F; Fidecicchi T; Gambacciani M
    Eur J Contracept Reprod Health Care; 2024 Jun; 29(3):93-102. PubMed ID: 38683756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
    Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hormonal contraception.
    Calderoni ME; Coupey SM
    Adolesc Med Clin; 2005 Oct; 16(3):517-37. PubMed ID: 16183537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal contraception in women with endometriosis: a systematic review.
    Grandi G; Barra F; Ferrero S; Sileo FG; Bertucci E; Napolitano A; Facchinetti F
    Eur J Contracept Reprod Health Care; 2019 Feb; 24(1):61-70. PubMed ID: 30664383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2. effects on hemostasis.
    Farris M; Bastianelli C; Rosato E; Brosens I; Benagiano G
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1129-1144. PubMed ID: 28712325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M; Kroll R; Lynen R; Bangerter K
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hormonal contraceptives-related venous thromboembolism.
    Hugon-Rodin J; Gompel A; Plu-Bureau G
    Eur J Endocrinol; 2014 Dec; 171(6):R221-30. PubMed ID: 25012200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting.
    DI Carlo C; Abbondanza M; Agnello A; Cavalli G; Driul L; Petriglia M; Tinelli A; Tirelli A; Tusei A; Grandi G
    Minerva Obstet Gynecol; 2021 Oct; 73(5):614-620. PubMed ID: 34751529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).
    Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit
    J Fam Plann Reprod Health Care; 2004 Jan; 30(1):43-5. PubMed ID: 15006313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hormonal contraception].
    Van Cauwenberge JR
    Rev Med Liege; 1992 May; 47(5):221-36. PubMed ID: 1604074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic risks of oral contraceptives.
    Rott H
    Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
    Vannuccini S; Biagiotti C; Esposto MC; La Torre F; Clemenza S; Orlandi G; Capezzuoli T; Petraglia F
    Gynecol Endocrinol; 2022 May; 38(5):398-402. PubMed ID: 35238265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.